cIn the past, biofilm-related research has focused mainly on axenic biofilms. However, in nature, biofilms are often composed of multiple species, and the resulting polymicrobial interactions influence industrially and clinically relevant outcomes such as performance and drug resistance. In this study, we show that Escherichia coli does not affect Candida albicans tolerance to amphotericin or caspofungin in an E. coli/C. albicans biofilm. In contrast, ofloxacin tolerance of E. coli is significantly increased in a polymicrobial E. coli/C. albicans biofilm compared to its tolerance in an axenic E. coli biofilm. The increased ofloxacin tolerance of E. coli is mainly biofilm specific, as ofloxacin tolerance of E. coli is less pronounced in polymicrobial E. coli/C. albicans planktonic cultures. Moreover, we found that ofloxacin tolerance of E. coli decreased significantly when E. coli/C. albicans biofilms were treated with matrix-degrading enzymes such as the -1,3-glucan-degrading enzyme lyticase. In line with a role for -1,3-glucan in mediating ofloxacin tolerance of E. coli in a biofilm, we found that ofloxacin tolerance of E. coli increased even more in E. coli/C. albicans biofilms consisting of a high--1,3-glucan-producing C. albicans mutant. In addition, exogenous addition of laminarin, a polysaccharide composed mainly of poly--1,3-glucan, to an E. coli biofilm also resulted in increased ofloxacin tolerance. All these data indicate that -1,3-glucan from C. albicans increases ofloxacin tolerance of E. coli in an E. coli/C. albicans biofilm.
Biofilms are well-structured populations of microbial cells that are attached to a surface and embedded in a self-produced extracellular polymer matrix (1, 2). Such biofilms can be found in natural, industrial, and medical environments and can be employed for a variety of biotechnological applications (3-5). However, these structured communities also have great significance for public health, as biofilm microbial cells exhibit increased tolerance to antimicrobial agents (6). Biofilms consisting of a single pathogenic microorganism have been extensively studied in the past, and multiple processes and various structural elements have previously been implicated in axenic biofilm formation, i.e., biofilms consisting of one microbial species. For the Gram-negative bacterium Escherichia coli, examples include motility, virulence, surface appendages, polysaccharides, toxin-antitoxin modules, quorum sensing, and several stress responses (7,8). In the fungal opportunistic pathogen Candida albicans, morphological transition, quorum sensing, adhesins, and several transcription regulators are implicated in axenic biofilm development (9-12). However, as it is becoming increasingly clear that polymicrobial biofilms are the dominant form in nature, the scientific focus is shifting toward polymicrobial biofilms. Communication, cell wall components, metabolic commensalism, and competition for nutrients and physical resources are emerging as important factors influencing the physiology of ...